Scientists use modelling to show the role of metabolism and signaling in cancer metastasis

June 07, 2016

Researchers have built a model to investigate the metastasis of cancer by examining the metabolism of breast epithelial cells and look at the role of signaling. This research, published in PLOS Computational Biology, may contribute to the development of cell specific anti-cancer interventions.

Scientists, led by Ottar Rolfssonat the University of Iceland, have built a mathematical model to examine the metabolism of breast epithelium -- as the majority of breast cancers originate from these cells. The model specifically looks at the process of epithelial to mesenchymal transition (EMT) which is an important event during development and cancer metastasis.

One of the key metabolic alterations that takes place during EMT is that of the epidermal growth factor receptor (EGFR) which is a pathway that regulates growth, survival, proliferation, and differentiation in mammalian cells. EFGR signaling often affects metabolic rate in tumor cells and controls their progression -- the dysregulation of signaling pathways during this process is therefore a hallmark of metastasis.

The scientists' model looks at the EGFR signaling cascade to investigate crosstalk between EFGR signaling and EMT in cell culture models of human breast epithelium. The model was then used to obtain a list of potential signaling and metabolic targets of EMT.

These targets may aid in the understanding of the molecular mechanisms that underlie EMT and cancer metastasis. The results also show how the metabolic signposts of cancer cell growth and EMT can be predicted based on the transcriptome analysis of EGFR signaling genes alone (where current methods are inconsistent) -- thus supporting the idea of cell specific anti-cancer interventions.
-end-
In your coverage please use this URL to provide access to the freely available article in PLOS Computational Biology: http://dx.plos.org/10.1371/journal.pcbi. pcbi.1004924

Published paper: http://journals.plos.org/ploscompbiol/article?id=info:doi/10.1371/journal.pcbi.1004924

Press preview: http://blogs.plos.org/everyone/files/2016/06/pcbi.1004924-Press-Preview.pdf

Contact:

Ottar Rolfsson
ottarr@hi.is

Citation: Choudhary KS, Rohatgi N, Halldorsson S, Briem E, Gudjonsson T, Gudmundsson S, et al. (2016) EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT. PLoS Comput Biol 12(6): e1004924. doi:10.1371/journal. pcbi.1004924

Image Credit: VCU Libraries / Flickr

Image Link: http://blogs.plos.org/everyone/files/2016/06/Rolfsson-striking-image.jpg

Funding: This project is supported by Icelandic Research Fund (RANNIS) project grants (Grant no. 130591-051 and 152358-051). KSC was supported by Icelandic Research Fund (RANNIS) postdoctoral grant (Grant no. 152369-051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Back to the Top

About PLOS Computational Biology

PLOS Computational Biology features works of exceptional significance that further our understanding of living systems at all scales through the application of computational methods. For more information follow @PLOSCompBiol on Twitter or contact ploscompbiol@plos.org.

Media and Copyright Information

For information about PLOS Computational Biology relevant to journalists, bloggers and press officers, including details of our press release process and embargo policy, visit http://journals.plos.org/ploscompbiol/s/press-and-media .

PLOS Journals publish under a Creative Commons Attribution License, which permits free reuse of all materials published with the article, so long as the work is cited.

About the Public Library of Science

The Public Library of Science (PLOS) PLOS is a nonprofit publisher and advocacy organization founded to accelerate progress in science and medicine by leading a transformation in research communication. For more information, visit http://www.plos.org.

Disclaimer

This press release refers to upcoming articles in PLOS Computational Biology. The releases have been provided by the article authors and/or journal staff. Any opinions expressed in these are the personal views of the contributors, and do not necessarily represent the views or policies of PLOS. PLOS expressly disclaims any and all warranties and liability in connection with the information found in the release and article and your use of such information.

PLOS

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.